Recently, it has been demonstrated that, by inhibiting CSF-1R, TAMs can reprogram from the M2 to the M1 phenotype in the TME, work in concert with T cells, and participate in tumor elimination [23,24,25]. The gene discussed is CSF1R; the disease is neoplasm.